ES8604693A1 - Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico. - Google Patents

Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.

Info

Publication number
ES8604693A1
ES8604693A1 ES535553A ES535553A ES8604693A1 ES 8604693 A1 ES8604693 A1 ES 8604693A1 ES 535553 A ES535553 A ES 535553A ES 535553 A ES535553 A ES 535553A ES 8604693 A1 ES8604693 A1 ES 8604693A1
Authority
ES
Spain
Prior art keywords
hsv
polypeptide
diagnostic product
molecularly cloned
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535553A
Other languages
English (en)
Other versions
ES535553A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27414977&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8604693(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES535553A0 publication Critical patent/ES535553A0/es
Publication of ES8604693A1 publication Critical patent/ES8604693A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO PARA DETECTAR UN ANTICUERPO O UN ANTIGENO CONTENIDO EN UNA MUESTRA DE FLUIDO DE ORIGEN BIOLOGICO. COMPRENDE: A) PONER EN CONTACTO UNA MUESTRA DE FLUIDO DE ORIGEN BIOLOGICO CON UN PRODUCTO PARA DIAGNOSTICO, QUE COMPRENDE UN POLIPEPTIDO FIJADO A UNA MEMBRANA QUE TIENE DETERMINANTES ANTIGENICOS CAPACES DE FIJAR ESPECIFICAMENTE UN ANTICUERPO ESPECIFICO PARA VIRUS DE HERPES SIMPLEX, ESTANDO DICHO POLIPEPTIDO ASOCIADO FUNCIONALMENTE CON UNA MEMBRANA DE UNA LINEA DE CELULAS CONTINUA, ESTABLE Y RECOMBINANTE, CAPAZ DE REALIZAR SU PRODUCCION, A FIN DE: 1) FIJAR DICHO PRODUCTO PARA DIAGNOSTICO CON EL ANTICUERPO; O 2) PONER EN ASOCIADION CON LA MUESTRA DE FLUIDO DICHO PRODUCTO PARA DIAGNOSTICO QUE TIENE LOS MISMOS DETERMINANTES ANTIGENICOS QUE DICHO ANTIGENO DE LA MUESTRA; Y B) DETECTAR LA FIJACION DE LA OPERACION A) SI SE DESEA DETECTAR UN ANTICUERPO O DETECTAR EL ANTIGENO DE MUESTRA UTILIZANDO UN ANALISIS COMPETITIVO SI SE DESEA DETECTAR EL ANTIGENO.
ES535553A 1983-08-30 1984-08-30 Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico. Expired ES8604693A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52791683A 1983-08-30 1983-08-30
US54755283A 1983-10-31 1983-10-31
US58776384A 1984-03-09 1984-03-09

Publications (2)

Publication Number Publication Date
ES535553A0 ES535553A0 (es) 1986-02-16
ES8604693A1 true ES8604693A1 (es) 1986-02-16

Family

ID=27414977

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535553A Expired ES8604693A1 (es) 1983-08-30 1984-08-30 Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.

Country Status (11)

Country Link
EP (1) EP0139416B2 (es)
JP (1) JPH0658372B2 (es)
AU (2) AU583478B2 (es)
CA (1) CA1243945A (es)
DE (1) DE3485974T3 (es)
DK (1) DK171976B1 (es)
ES (1) ES8604693A1 (es)
GR (1) GR80219B (es)
IE (1) IE58973B1 (es)
IL (1) IL72784A (es)
NZ (1) NZ209307A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3674567D1 (de) * 1985-03-18 1990-10-31 Royal Free Hosp School Med Verbesserungen in bezug auf nachweis von viren und antikoerpern.
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US7084251B1 (en) 1987-02-12 2006-08-01 Genentech, Inc. Methods and Deoxyribonucleic acid for the preparation of tissue factor protein
US6994988B1 (en) 1987-02-12 2006-02-07 Genetech, Inc. Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
US6710169B2 (en) 1987-10-02 2004-03-23 Genentech, Inc. Adheson variants
EP1201756A3 (en) * 1988-12-22 2002-10-30 Genentech, Inc. Method for preparing water soluble polypeptides
US8541002B2 (en) 2003-09-12 2013-09-24 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
JP2013524806A (ja) 2010-04-23 2013-06-20 ゲノミク ビジョン 分子コーミングを用いるゲノムｄｎａ及び感染性ウイルスｄｎａの検出によるウイルス感染の診断

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
JPS5523402A (en) * 1978-03-24 1980-02-19 Yatoron:Kk Manufacture of reagent for indirect red corpuscle agglutination which absorbs simultaneously heterogenetic antibody
DE2949031A1 (de) * 1978-12-15 1980-07-17 Sandoz Ag Vakzine
JPS5631646A (en) * 1979-08-23 1981-03-31 Fujirebio Inc Sensitized latex for herpes virus infection diagnosis
JPS57156559A (en) * 1981-03-24 1982-09-27 Fumiaki Taguchi Measuring method for neutralization antibody
FR2519650B1 (fr) * 1982-01-13 1985-07-12 Univ Paris Curie Lignees cellulaires hybrides murines anti-herpes, procede d'obtention, anticorps monoclonaux anti-herpes, applications biologiques
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
AU1678783A (en) * 1982-07-20 1984-01-26 Molecular Genetics, Inc. Production of herpes simplex viral proteins
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein

Also Published As

Publication number Publication date
EP0139416A2 (en) 1985-05-02
IE842209L (en) 1985-02-28
EP0139416B1 (en) 1992-11-04
DK412184A (da) 1985-04-12
AU3006189A (en) 1989-06-22
DE3485974T2 (de) 1993-05-13
DK171976B1 (da) 1997-09-01
NZ209307A (en) 1990-07-26
GR80219B (en) 1985-01-02
AU3242484A (en) 1985-03-07
DK412184D0 (da) 1984-08-29
IL72784A0 (en) 1984-11-30
ES535553A0 (es) 1986-02-16
AU623375B2 (en) 1992-05-14
AU583478B2 (en) 1989-05-04
CA1243945A (en) 1988-11-01
JPS60155974A (ja) 1985-08-16
IE58973B1 (en) 1993-12-15
EP0139416A3 (en) 1987-01-14
EP0139416B2 (en) 2003-11-05
DE3485974D1 (de) 1992-12-10
DE3485974T3 (de) 2004-07-22
JPH0658372B2 (ja) 1994-08-03
IL72784A (en) 1990-07-26

Similar Documents

Publication Publication Date Title
EP0344940A3 (en) Antibodies to human papillomavirus latent proteins, diagnostic systems and methods
ES8705036A1 (es) Procedimiento para preparar una vacuna que comprende un polipeptido fijado a una membrana
EP0120551A3 (en) Yeast expression systems with vectors having gapdh or pyk promoters, and synthesis of foreign proteins
EP0274394A3 (en) Chimeric antibody with specificity to human b cell surface antigen
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
AU591461B2 (en) Peptide antibodies and their use in detecting oncogene products
EP0376746A3 (en) Gene family of tumor-associated antigens
NZ210106A (en) Immunological compositions containing anti-idiotype antibodies
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
GB8404368D0 (en) Monoclonal antibodies to human cytomegalovirus
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
EP0194578A3 (en) Proteins immobilised on polyamides or cellulose hydrate and the use thereof for the preparation of biocatalysts, test strips or chromatography materials
AU525403B2 (en) Purified antigen
ATE51709T1 (de) Antigen im zusammenhang mit der fruehzeitigen feststellung von schwangerschaft bei saeugern.
IL69374A0 (en) Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
EP0299354A3 (en) Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use
EP0293827A3 (en) Assay for leishmaniasis
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
EP0262571A3 (en) Monoclonal antibodies against ifn-omega, process for preparing them and their use in the purification and detection of ifn-omega
EP0267622A3 (en) Method for detecting anti-adult t cell leukemia virus antibody
EP0428629A4 (en) Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
AU2900184A (en) Membrane antigens generated from pooled cells and monoclonal antibodies
Scalia Microcarriers in enzyme immunoassay for the detection of herpes simplex virus antigens
Pornsooksawang Demand for ethylene.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051119